Thomas Ryll

Title: Thomas Ryll: Innovator in Glycoprotein Production

Introduction

Thomas Ryll is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of glycoprotein production, holding a total of 5 patents. His work focuses on innovative processes that enhance the efficiency and effectiveness of mammalian cell culture.

Latest Patents

Ryll's latest patents include a novel process for the preparation of glycoproteins by mammalian cell culture. This invention allows for the control of sialic acid content in glycoproteins over a broad range by manipulating the cell culture environment. The processes he developed modify the sialic acid content through changes in cell culture parameters that affect cell-specific productivity. Preferred embodiments of his invention include controlling the osmolality of the cell culture and the concentration of a transcription enhancer during the production phase. Additionally, he has developed novel preparations of soluble type 1 tumor necrosis factor immunoglobulin G1, which have applications in treating inflammatory or immune-related disorders.

Career Highlights

Throughout his career, Thomas Ryll has worked with prominent companies such as Genentech, Inc. and Genetech, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and glycoprotein production.

Collaborations

One of his notable coworkers is Tina M Etcheverry, with whom he has collaborated on various projects related to his inventions.

Conclusion

Thomas Ryll's innovative work in glycoprotein production has made a significant impact in the biotechnology field. His patents reflect a deep understanding of mammalian cell culture processes and their applications in medical treatments.